Response shift in coronary artery disease.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Mar 2024
Historique:
accepted: 10 11 2023
medline: 26 2 2024
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: ppublish

Résumé

Patients with coronary artery disease (CAD) experience significant angina symptoms and lifestyle changes. Revascularization procedures can result in better patient-reported outcomes (PROs) than optimal medical therapy (OMT) alone. This study evaluates the impact of response shift (RS) on changes in PROs of patients with CAD across treatment strategies. Data were from patients with CAD in the Alberta Provincial Project on Outcome Assessment in Coronary Heart Disease (APPROACH) registry who completed the 16-item Canadian version of the Seattle Angina Questionnaire at 2 weeks and 1 year following a coronary angiogram. Multi-group confirmatory factor analysis (MG-CFA) was used to assess measurement invariance across treatment groups at week 2. Longitudinal MG-CFA was used to test for RS according to receipt of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or optimal medical therapy (OMT) alone. Of the 3116 patients included in the analysis, 443 (14.2%) received CABG, 2049(65.8%) PCI, and the remainder OMT alone. The MG-CFA revealed a partial-strong invariance across the treatment groups at 2 weeks (CFI = 0.98, RMSEA [90% CI] = 0.05 [0.03, 0.06]). Recalibration RS was detected on the Angina Symptoms and Burden subscale and its magnitude in the OMT, PCI, and CABG groups were 0.32, 0.28, and 0.53, respectively. After adjusting for RS effects, the estimated target changes were largest in the CABG group and negligible in the OMT group. Adjusting for RS is recommended in studies that use SAQ-CAN to assess changes in patients with CAD who have received revascularization versus OMT alone.

Identifiants

pubmed: 38133786
doi: 10.1007/s11136-023-03564-1
pii: 10.1007/s11136-023-03564-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-776

Subventions

Organisme : CIHR
ID : 400774
Pays : Canada
Organisme : CIHR
ID : 400774
Pays : Canada

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Lavallee, D. C., Chenok, K. E., Love, R. M., Petersen, C., Holve, E., Segal, C. D., & Franklin, P. D. (2016). Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Affairs, 35(4), 575–582.
pubmed: 27044954 doi: 10.1377/hlthaff.2015.1362
Wiklund, I. (2004). Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life. Fundamental & Clinical Pharmacology, 18(3), 351–363.
doi: 10.1111/j.1472-8206.2004.00234.x
Deshpande, P. R., Rajan, S., Sudeepthi, B. L., & Nazir, C. A. (2011). Patient-reported outcomes: A new era in clinical research. Perspectives in Clinical Research, 2(4), 137.
pubmed: 22145124 pmcid: 3227331 doi: 10.4103/2229-3485.86879
Mamiya, H., Lix, L. M., Gardner, W., Bartlett, S. J., Ahmed, S., & Buckeridge, D. L. (2017). Montreal Accord on Patient-Reported Outcomes (PROs) use series—Paper 5: Patient-reported outcomes can be linked to epidemiologic measures to monitor populations and inform public health decisions. Journal of Clinical Epidemiology, 89, 142–147.
pubmed: 28435100 doi: 10.1016/j.jclinepi.2017.04.018
Cruz Rivera, S., Dickens, A. P., Aiyegbusi, O. L., Flint, R., Fleetcroft, C., McPherson, D., Collis, P., & Calvert, M. J. (2021). Patient-reported outcomes in the regulatory approval of medical devices. Nature medicine, 27(12), 2067–2068.
pubmed: 34785789 doi: 10.1038/s41591-021-01546-9
Burke, L., Kennedy, D., Miskala, P., Papadopoulos, E., & Trentacosti, A. (2008). The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clinical Pharmacology & Therapeutics, 84(2), 281–283.
doi: 10.1038/clpt.2008.128
Serruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., Van Den Brand, M., & Bass, E. J. (2009). Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New England Journal of Medicine, 360(10), 961–972.
pubmed: 19228612 doi: 10.1056/NEJMoa0804626
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., & Don, C. W. (2022). 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(3), e4–e17.
pubmed: 34882436
Kappetein, A. P., van Mieghem, N. M., & Head, S. J. (2016). Revascularization options: Coronary artery bypass surgery and percutaneous coronary intervention. Heart Failure Clinics, 12(1), 135–139.
pubmed: 26567980 doi: 10.1016/j.hfc.2015.08.011
Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., & Solomon, S. D. (2012). Strategies for multivessel revascularization in patients with diabetes. New England Journal of Medicine, 367(25), 2375–2384.
pubmed: 23121323 doi: 10.1056/NEJMoa1211585
Wong, M. S., & Chair, S. Y. (2007). Changes in health-related quality of life following percutaneous coronary intervention: A longitudinal study. International Journal of Nursing Studies, 44(8), 1334–1342.
pubmed: 16982057 doi: 10.1016/j.ijnurstu.2006.07.011
Staniūtė, M., & Brožaitienė, J. (2010). Changes in health-related quality of life among patients with coronary artery disease: A 2-year follow-up. Medicina, 46(12), 843.
pubmed: 21532289 doi: 10.3390/medicina46120118
McKee, G. (2009). Are there meaningful longitudinal changes in health related quality of life—SF36, in cardiac rehabilitation patients? European Journal of Cardiovascular Nursing, 8(1), 40–47.
pubmed: 18504159 doi: 10.1016/j.ejcnurse.2008.04.004
Boini, S., Briançon, S., Guillemin, F., Galan, P., & Hercberg, S. (2006). Occurrence of coronary artery disease has an adverse impact on health-related quality of life: A longitudinal controlled study. International Journal of Cardiology, 113(2), 215–222.
pubmed: 16386811 doi: 10.1016/j.ijcard.2005.11.016
Sajobi, T. T., Wang, M., Awosoga, O., Santana, M., Southern, D., Liang, Z., Galbraith, D., Wilton, S. B., Quan, H., & Graham, M. M. (2018). Trajectories of health-related quality of life in coronary artery disease. Circulation Cardiovascular Quality and Outcomes, 11(3), e003661.
pubmed: 29545392 doi: 10.1161/CIRCOUTCOMES.117.003661
Sawatzky, R., Sajobi, T. T., Brahmbhatt, R., Chan, E. K., Lix, L. M., & Zumbo, B. D. (2017). Longitudinal change in response processes: A response shift perspective. Understanding and investigating response processes in validation research (pp. 251–276). Springer.
doi: 10.1007/978-3-319-56129-5_14
Vanier, A., Oort, F. J., McClimans, L., Ow, N., Gulek, B. G., Böhnke, J. R., Sprangers, M., Sébille, V., & Mayo, N. (2021). Response shift in patient-reported outcomes: Definition, theory, and a revised model. Quality of Life Research, 30(12), 3309–3322.
pubmed: 33909187 pmcid: 8602159 doi: 10.1007/s11136-021-02846-w
Reeve, B. B. (2010). An opportunity to refine our understanding of “response shift” and to educate researchers on designing quality research studies: Response to Ubel, Peeters, and Smith. Quality of Life Research, 19, 473–475.
pubmed: 20336490 doi: 10.1007/s11136-010-9612-x
Lawal, O. A., Awosoga, O., Santana, M. J., James, M. T., Southern, D. A., Wilton, S. B., Graham, M. M., Knudtson, M., Lu, M., & Quan, H. (2020). Psychometric evaluation of a Canadian version of the Seattle Angina Questionnaire (SAQ-CAN). Health and Quality of Life Outcomes, 18(1), 1–10.
doi: 10.1186/s12955-020-01627-2
Lix, L. M., Chan, E. K., Sawatzky, R., Sajobi, T. T., Liu, J., Hopman, W., & Mayo, N. (2016). Response shift and disease activity in inflammatory bowel disease. Quality of Life Research, 25(7), 1751–1760.
pubmed: 26589529 doi: 10.1007/s11136-015-1188-z
Auneau-Enjalbert, L., Blanchin, M., Giral, M., Meurette, A., Morelon, E., Albano, L., Hardouin, J.-B., & Sébille, V. (2022). Investigation of measurement invariance in longitudinal health-related quality of life in preemptive or previously dialyzed kidney transplant recipients. Quality of Life Research, 31(2), 607–620.
pubmed: 34173173 doi: 10.1007/s11136-021-02916-z
Gregorich, S. E. (2006). Do self-report instruments allow meaningful comparisons across diverse population groups? Testing measurement invariance using the confirmatory factor analysis framework. Medical Care, 44(11 Suppl 3), S78.
pubmed: 17060839 pmcid: 1808350 doi: 10.1097/01.mlr.0000245454.12228.8f
Cheung, G. W., & Rensvold, R. B. (2002). Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling, 9(2), 233–255.
doi: 10.1207/S15328007SEM0902_5
Oort, F. J. (2005). Using structural equation modeling to detect response shifts and true change. Quality of Life Research, 14(3), 587–598.
pubmed: 16022054 doi: 10.1007/s11136-004-0830-y
Bollen, K. A. (1989). Structural equations with latent variables (Vol 210). John Wiley & Sons.
doi: 10.1002/9781118619179
Cohen, J. (2013). Statistical power analysis for the behavioral sciences. Routledge.
doi: 10.4324/9780203771587
Browne, M. W. (1993). Alternative ways of assessing model fit. Testing structural equation models.
Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological bulletin, 107(2), 238.
pubmed: 2320703 doi: 10.1037/0033-2909.107.2.238
Muthén, L. K., & Muthén, B. (2017). Mplus user’s guide: Statistical analysis with latent variables, user’s guide. Muthén & Muthén.
Kline, R. B. (2015). Principles and practice of structural equation modeling. Guilford Publications.
Oreel, T. H., Nieuwkerk, P. T., Hartog, I. D., Netjes, J. E., Vonk, A. B. A., Lemkes, J., van Laarhoven, H. W. M., Scherer-Rath, M., Henriques, J. P. S., Oort, F. J., Sprangers, M. A. G., & Verdam, M. G. E. (2022). Response shift after coronary revascularization. Quality of Life Research, 31(2), 437–450.
pubmed: 34159517 doi: 10.1007/s11136-021-02902-5
Gandhi, P. K., Ried, L. D., Huang, I.-C., Kimberlin, C. L., & Kauf, T. L. (2013). Assessment of response shift using two structural equation modeling techniques. Quality of Life Research, 22(3), 461–471.
pubmed: 22476611 doi: 10.1007/s11136-012-0171-1
Graham, M. M., Norris, C. M., Galbraith, P. D., Knudtson, M. L., & Ghali, W. A. (2006). Quality of life after coronary revascularization in the elderly. European Heart Journal, 27(14), 1690–1698.
pubmed: 16717072 doi: 10.1093/eurheartj/ehl038
Kulik, A. (2017). Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: What do the trials tell us? Current Opinion in Cardiology, 32(6), 707–714.
pubmed: 28834794 doi: 10.1097/HCO.0000000000000458
Borkon, A. M., Muehlebach, G. F., House, J., Marso, S. P., & Spertus, J. A. (2002). A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. The Annals of Thoracic Surgery, 74(5), 1526–1530.
pubmed: 12440603 doi: 10.1016/S0003-4975(02)04063-8
Schwartz, C. E., Bode, R., Repucci, N., Becker, J., Sprangers, M. A., & Fayers, P. M. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15(9), 1533–1550.
pubmed: 17031503 doi: 10.1007/s11136-006-0025-9
Schwartz, C. E., & Sendor, R. M. (1999). Helping others helps oneself: Response shift effects in peer support. Social Science & Medicine, 48(11), 1563–1575.
doi: 10.1016/S0277-9536(99)00049-0
Ilie, G., Bradfield, J., Moodie, L., Lawen, T., Ilie, A., Lawen, Z., Blackman, C., Gainer, R., & Rutledge, R. D. (2019). The role of response-shift in studies assessing quality of life outcomes among cancer patients: A systematic review. Frontiers in Oncology, 9, 783.
pubmed: 31482068 pmcid: 6710367 doi: 10.3389/fonc.2019.00783
Powden, C. J., Hoch, M. C., & Hoch, J. M. (2018). Examination of response shift after rehabilitation for orthopedic conditions: A systematic review. Journal of Sport Rehabilitation, 27(5), 469–479.
pubmed: 28605312 doi: 10.1123/jsr.2017-0104
Sprangers, M. A., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine, 48(11), 1507–1515.
doi: 10.1016/S0277-9536(99)00045-3
Schwartz, C. E., & Sprangers, M. A. (2000). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. In C. E. Schwartz & A. G. Mirjam (Eds.), Sprangers Adaptation to changing health: Response shift in quality-of-life research. APA.
doi: 10.1037/10382-000
Sawatzky, R., Kwon, J.-Y., Barclay, R., Chauhan, C., Frank, L., van den Hout, W. B., Nielsen, L. K., Nolte, S., & Sprangers, M. A. (2021). Implications of response shift for micro-, meso-, and macro-level healthcare decision-making using results of patient-reported outcome measures. Quality of Life Research, 30(12), 3343–3357.
pubmed: 33651278 pmcid: 8602130 doi: 10.1007/s11136-021-02766-9
Hartog, I. D., Willems, D. L., van den Hout, W. B., Scherer-Rath, M., Oreel, T. H., Henriques, J. P. S., Nieuwkerk, P. T., van Laarhoven, H. W. M., & Sprangers, M. A. G. (2019). Influence of response shift and disposition on patient-reported outcomes may lead to suboptimal medical decisions: A medical ethics perspective. BMC Medical Ethics, 20(1), 61.
pubmed: 31510994 pmcid: 6737596 doi: 10.1186/s12910-019-0397-3
Sawatzky, R., Chan, E. K. H., Zumbo, B. D., Ahmed, S., Bartlett, S. J., Bingham, C. O., 3rd., Gardner, W., Jutai, J., Kuspinar, A., Sajobi, T., & Lix, L. M. (2017). Montreal Accord on Patient-Reported Outcomes (PROs) use series-Paper 7: Modern perspectives of measurement validation emphasize justification of inferences based on patient reported outcome scores. Journal of Clinical Epidemiology, 89, 154–159.
pubmed: 27998744 doi: 10.1016/j.jclinepi.2016.12.002
Norris, C. M., Spertus, J. A., Jensen, L., Johnson, J., Hegadoren, K. M., & Ghali, W. A. (2008). Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circulation: Cardiovascular Quality and Outcomes, 1(2), 123–130.
pubmed: 20031799
Lappalainen, L., Stenvall, H., Lavikainen, P., Miettinen, H., Martikainen, J., Sintonen, H., Tolppanen, A.-M., Roine, R. P., & Hartikainen, J. (2021). Patient-reported outcomes in coronary artery disease: The relationship between the standard, disease-specific set by the International Consortium for Health Outcomes Measurement (ICHOM) and the generic health-related quality of life instrument 15D. Health and Quality of Life Outcomes, 19(1), 1–10.
doi: 10.1186/s12955-021-01841-6
Sébille, V., Lix, L. M., Ayilara, O. F., Sajobi, T. T., Janssens, A. C. J. W., Sawatzky, R., Sprangers, M. A. G., & Verdam, M. G. E. (2021). Critical examination of current response shift methods and proposal for advancing new methods. Quality of Life Research, 30(12), 3325–3342.
pubmed: 33595827 pmcid: 8602164 doi: 10.1007/s11136-020-02755-4

Auteurs

Oluwaseyi A Lawal (OA)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Oluwagbohunmi A Awosoga (OA)

Faculty of Health Sciences, University of Lethbridge, Lethbridge, Canada.

Maria J Santana (MJ)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Olawale F Ayilara (OF)

Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

Meng Wang (M)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Michelle M Graham (MM)

Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.

Colleen M Norris (CM)

Faculty of Nursing, University of Alberta, Edmonton, Canada.

Stephen B Wilton (SB)

Department of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Matthew T James (MT)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Department of Medicine, Cumming School of Medicine University of Calgary, Calgary, Canada.

Tolulope T Sajobi (TT)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada. ttsajobi@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH